4[1]Sun HC, Tang ZY, Li XM, et al. Microvessel density of hepatocellular carcinoma: its relationship with prognosis. J Cancer Res Clin Oncol, 1999,125(7) :419- 26
5[2]Gasparini G, Weidener N, Bevilacqua P,et al. Tumor microvessel density,p53 expression, tumor size and peritumoral lymphatic vessel invasion are relevant prognostic marker in node-negative breast carcinoma. J Clin Oncol,1994,12(3) :454-66
6[3]Weidner N. Current pathology methods for measuring intratumoral microvessel density within breast carcinima and other solid tumors. Breast Cancer Res Treat, 1995,36(2): 169-80
7[4]Folkman J. What is the evidence that tumors are angiogenesis dependent. J Natl Cancer Inst, 1990,82(1) :4-6
8[5]Jain R K. Dilivery of novel therapeutic agents in tumor: physiological barriers and strategies. J Natl Cancer Inst, 1989,81 (8) :570-6
5Jabra AA, Fishmen EK, Taylor GA. Hepatic masses in infants and children: CT evaluation[ J]. AJR, 1992,158:143 - 149.
6Ishak KG, Ghinz PR, et al. Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases[J]. Cancer,20:396- 422.
7King SJ, Babyn PS, Greeberg ML, et al. Value of CT in determining the respectability of hepatoblastoma before and after chemotherapy[J]. AJR, 1993,160:793
8Gonzalez-Crussi F, Upton MP, Maurer HS. Hepatoblastoma: attempt at characterization of histologic subtypes[J]. Am J Surg Pathol, 1982, 6:599 - 612.
